Cat. No.: X22-05-ZQ271
Gambogenic acid
Synonym: 173932-75-7; Gambogenic Acid; (Z)-4-[(1S,2S,13S,15R)-7-[(2E)-3,7-Dimethylocta-2,6-dienyl]-6,8-dihydroxy-17,17-dimethyl-5-(3-methylbut-2-enyl)-10,14-dioxo-3,16-dioxapentacyclo[11.4.1.02,11.02,15.04,9]octadeca-4,6,8,11-tetraen-15-yl]-2-methylbut-2-enoic acid
- CAS Number: 173932-75-7
- Compound CID: 10794070
Product Size
20 mg; 50 mg; 100 mg; 200 mg
Properties
Description
Gambogenic acid is an inhibitor of the FGFR signaling pathway in erlotinib-resistant non-small-cell lung cancer (NSCLC) and exhibits anti-tumor effects. Gambogenic acid acts is also an effective inhibitor of EZH2 that specifically and covalently binds to Cys668 within the EZH2-SET domain, and triggers EZH2 ubiquitination. This product can be used for research in the fields of medicine and pharmacy.
Molecular Formula
C38H46O8
Purity
≥98%, determined by HPLC.
Identity
Confirmed by MS and NMR.
Applications
Gambogenic acid can be used for research in the fields of medicine and pharmacy.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products
